Keyphrases
Previously Untreated
100%
Chronic Lymphocytic Leukemia
100%
Ibrutinib
100%
Circulating Immune Cells
100%
Healthy Donors
57%
Immune Parameters
42%
B Cells
28%
Cell Count
28%
Clinical Outcomes
14%
Cell Population
14%
Age-matched
14%
Adaptive Immune Response
14%
Tumor Immunity
14%
Natural Killer Cells
14%
Circulating Levels
14%
Plasmacytoid Dendritic Cells
14%
Effector Memory T Cells
14%
Immunophenotypic Profile
14%
Once-daily
14%
Regulatory T Cells
14%
Naïve T Cells
14%
Normal B Cells
14%
Myeloid-derived Suppressor Cells
14%
Innate Immune Cells
14%
Continuous Treatment
14%
Plateaued
14%
Monocyte Count
14%
Low Counts
14%
Innate Cells
14%
Non-classical Monocytes
14%
Immunology and Microbiology
Immunocompetent Cell
100%
Cell Population
75%
B Cell
75%
Cell Count
50%
Regulatory T Cell
25%
Immunosuppressive Drug
25%
Natural Killer Cell
25%
Plasmacytoid Dendritic Cell
25%
Memory T Cell
25%
Naive T Cell
25%
Myeloid-Derived Suppressor Cell
25%
Monocyte Count
25%